{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:07:26Z","timestamp":1792159646427,"version":"4.4.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002635","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:33:41Z","timestamp":1533648821000},"page":"e1002635","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8126-8177","authenticated-orcid":true,"given":"Anna","family":"Sidorchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Isomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-2010","authenticated-orcid":true,"given":"Yasmina","family":"Molero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-9447","authenticated-orcid":true,"given":"Clara","family":"Hellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-5485","authenticated-orcid":true,"given":"Lorena","family":"Fern\u00e1ndez de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mataix-Cols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"B Dell\u2019osso","year":"2013","journal-title":"Eur Psychiatry"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies","volume":"30","author":"TA Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"M Lader","year":"2011","journal-title":"Addiction"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"A Lembke","year":"2018","journal-title":"N Engl J Med"},{"key":"ref5","year":"2004"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"DS Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0269881110379307","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders","volume":"24","author":"SJ Wilson","year":"2010","journal-title":"J Psychopharmacol"},{"key":"ref8","year":"2016"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11126-005-2982-5","article-title":"Review of benzodiazepine use in children and adolescents","volume":"76","author":"MW Witek","year":"2005","journal-title":"Psychiatr Q"},{"key":"ref10","first-page":"CD005170","article-title":"Pharmacotherapy for anxiety disorders in children and adolescents","volume":"3","author":"JC Ipser","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","first-page":"CD001026","article-title":"Antidepressant and benzodiazepine for major depression","volume":"1","author":"TA Furukawa","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"T Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"ref13","first-page":"CD003031","article-title":"Prophylactic drug management for febrile seizures in children","volume":"2","author":"M Offringa","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","first-page":"CD003723","article-title":"Anticonvulsant therapy for status epilepticus","volume":"9","author":"M Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","year":"2018"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.9778\/cmajo.20130076","article-title":"Use of benzodiazepines and related drugs in Manitoba: a population-based study","volume":"2","author":"S Alessi-Severini","year":"2014","journal-title":"CMAJ Open"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"e007070","DOI":"10.1136\/bmjopen-2014-007070","article-title":"Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland","volume":"5","author":"K O\u2019Sullivan","year":"2015","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/CLEP.S31624","article-title":"Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study","volume":"4","author":"AK Steffenak","year":"2012","journal-title":"Clin Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-244X-9-72","article-title":"Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data","volume":"9","author":"E Acquaviva","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00228-016-2044-y","article-title":"Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users","volume":"72","author":"A Benard-Laribiere","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project","volume":"25","author":"C Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00228-004-0765-9","article-title":"Increased psychotropic drug consumption by children in the Netherlands during 1995\u20132001 is caused by increased use of methylphenidate by boys","volume":"60","author":"JG Hugtenburg","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/pds.3466","article-title":"Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines","volume":"22","author":"MJ Bijlsma","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"M Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pds.4123","article-title":"Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study","volume":"26","author":"A Benard-Laribiere","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/acps.12155","article-title":"Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark","volume":"129","author":"HC Steinhausen","year":"2014","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08039488.2011.644809","article-title":"Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study","volume":"66","author":"D Gyllenberg","year":"2012","journal-title":"Nord J Psychiatry"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/cap.2009.0003","article-title":"Psychotropic drug use among Icelandic children: a nationwide population-based study","volume":"19","author":"H Zoega","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1\u20132","key":"ref29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addbeh.2010.09.003","article-title":"Psychotropic medication history of inpatient adolescents\u2014is there a rationale for benzodiazepine prescription?","volume":"36","author":"R Ilomaki","year":"2011","journal-title":"Addict Behav"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11096-015-0138-8","article-title":"Benzodiazepine prescribing guideline adherence and misuse potential in Irish minors","volume":"37","author":"KD Murphy","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ps.62.8.pss6208_0900","article-title":"Five-year trajectories of long-term benzodiazepine use by adolescents: patient, provider, and medication factors","volume":"62","author":"HH Yeh","year":"2011","journal-title":"Psychiatr Serv"},{"key":"ref32","article-title":"Annex I\u2014Definitions (Rev 4)","year":"2017"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09540260500093768","article-title":"The epidemiology of psychotropic drug use in children and adolescents","volume":"17","author":"M Bonati","year":"2005","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bcpt.12706","article-title":"Trends in off-label prescribing of sedatives, hypnotics and antidepressants among children and adolescents\u2014a Danish, nationwide register-based study","volume":"120","author":"ES Nielsen","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.111.2.291","article-title":"Risk factors for unlicensed and off-label drug use in children outside the hospital","volume":"111","author":"E Schirm","year":"2003","journal-title":"Pediatrics"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"B Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"JF Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00127-002-0582-3","article-title":"Young cases of schizophrenia identified in a national inpatient register\u2014are the diagnoses valid?","volume":"37","author":"C Dalman","year":"2002","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08039480500360906","article-title":"Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses","volume":"59","author":"B Ekholm","year":"2005","journal-title":"Nord J Psychiatry"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e007520","DOI":"10.1136\/bmjopen-2014-007520","article-title":"Validity and reliability of chronic tic disorder and obsessive-compulsive disorder diagnoses in the Swedish National Patient Register","volume":"5","author":"C Ruck","year":"2015","journal-title":"BMJ Open"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0447.2011.01747.x","article-title":"Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden","volume":"124","author":"C Sellgren","year":"2011","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"JF Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"JF Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"ref44","year":"2018"},{"key":"ref45","unstructured":"Ministry of Health and Social Affairs. [Ordinance (2002:687) on pharmaceutical benefits.] Stockholm: Swedish Parliament; 2002 [cited 2018 Jul 23]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.riksdagen.se\/sv\/dokument-lagar\/dokument\/svensk-forfattningssamling\/forordning-2002687-om-lakemedelsformaner-mm_sfs-2002-687\" xlink:type=\"simple\">https:\/\/www.riksdagen.se\/sv\/dokument-lagar\/dokument\/svensk-forfattningssamling\/forordning-2002687-om-lakemedelsformaner-mm_sfs-2002-687<\/ext-link>."},{"key":"ref46","year":"2011"},{"key":"ref47","year":"2017"},{"key":"ref48","first-page":"345","article-title":"Modern epidemiology","author":"S Greenland","year":"2008"},{"key":"ref49","unstructured":"SAS Institute. SAS\/STAT Software. Version 9.4. Cary (NC): SAS Institute; 2013."},{"key":"ref50","unstructured":"FASS Allm\u00e4nhet. Stockholm: FASS; 2018 [cited 2018 Jul 2]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fass.se\" xlink:type=\"simple\">http:\/\/www.fass.se<\/ext-link>."},{"key":"ref51","unstructured":"The Stockholm County Council, the Stockholm Drug and Therapeutics Committee. [The wise list 2017: psychiatry.] Stockholm: Stockholm County Council; 2017 [cited 2018 Jun 25]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/klokalistan.janusinfo.se\/2017\/Psykiatri\/\" xlink:type=\"simple\">http:\/\/klokalistan.janusinfo.se\/2017\/Psykiatri\/<\/ext-link>."},{"key":"ref52","unstructured":"Medical Products Agency. [Sleep disorders in children\u2014new recommendations.] Uppsala: Medical Products Agency; 2015 [cited 2018 Jun 25]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/lakemedelsverket.se\/upload\/halso-och-sjukvard\/behandlingsrekommendationer\/Somnstorningar_hos_barn.pdf\" xlink:type=\"simple\">https:\/\/lakemedelsverket.se\/upload\/halso-och-sjukvard\/behandlingsrekommendationer\/Somnstorningar_hos_barn.pdf<\/ext-link>."},{"key":"ref53","year":"2010"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1753-2000-2-26","article-title":"A three-country comparison of psychotropic medication prevalence in youth","volume":"2","author":"JM Zito","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"TW Park","year":"2015","journal-title":"BMJ"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"EC Sun","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamapsychiatry.2013.3074","article-title":"National trends in the mental health care of children, adolescents, and adults by office-based physicians","volume":"71","author":"M Olfson","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2296-14-191","article-title":"General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis","volume":"14","author":"C Sirdifield","year":"2013","journal-title":"BMC Fam Pract"},{"key":"ref59","unstructured":"Center for Epidemiology and Community Medicine. [What diagnoses account for the growth of young adult healthcare consumption for psychiatric conditions? Fact sheet 2016:1.] Stockholm: Stockholm County Council; 2016 [cited 2018 Jun 28]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.dok.slso.sll.se\/CES\/FHG\/Psykisk_halsa_och_ohalsa\/Faktablad\/Unga-vuxnas-vardkonsumtion-for-psykiatriska-tillstand-2016.1.pdf\" xlink:type=\"simple\">http:\/\/www.dok.slso.sll.se\/CES\/FHG\/Psykisk_halsa_och_ohalsa\/Faktablad\/Unga-vuxnas-vardkonsumtion-for-psykiatriska-tillstand-2016.1.pdf<\/ext-link>."},{"key":"ref60","unstructured":"Center for Epidemiology and Community Medicine. [Continued increase in psychiatric care consumption among young people in Stockholm County in 2015. Fact sheet 2016:3.] Stockholm: Stockholm County Council; 2016 [cited 2018 Jun 25]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.dok.slso.sll.se\/CES\/FHG\/Psykisk_halsa_och_ohalsa\/Faktablad\/Fortsatt-okning-av-psykiatrisk-vardkonsumtion-bland-unga-i-Sthlms-lan-Faktablad-2016.3.pdf\" xlink:type=\"simple\">http:\/\/www.dok.slso.sll.se\/CES\/FHG\/Psykisk_halsa_och_ohalsa\/Faktablad\/Fortsatt-okning-av-psykiatrisk-vardkonsumtion-bland-unga-i-Sthlms-lan-Faktablad-2016.3.pdf<\/ext-link>."},{"key":"ref61","year":"2014"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0277-9536(96)00296-1","article-title":"Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time\u2014a 13-year follow-up in a Swedish community","volume":"44","author":"D Isacson","year":"1997","journal-title":"Soc Sci Med"},{"key":"ref63","year":"2011"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:48:06Z","timestamp":1540241286000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002635"}},"subtitle":[],"editor":[{"given":"Lars \u00c5ke","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002635","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]}}}